In-Person Access Only | Accreditation TBD
All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $25 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team.
The 10th Annual West Oncology Conference will serve as a valuable forum for presenting and discussing new research findings in oncology education.
Learners will be provided updates on practice-changing data in breast cancers, genitourinary cancers, hematological malignancies, gastrointestinal cancers, and lung cancers – all in a practical and interactive format, fostering discussion and impacting patient clinical outcomes. This accredited meeting will be an in-person conference with on-demand access for registered attendees.
Conference Agenda
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
8:35 AM
Lifestyle Tips and Strategies
8:40 AM
Updates from ASCO GI
9:00 AM
Management of Colorectal Liver Metastases
9:20 AM
Panel Discussion and Q&A - Gastrointestinal Cancer
9:35 AM
Adjuvant vs Neoadjuvant Therapy and Sequencing in Lung Cancer
10:10 AM
Panel Discussion and Q&A - Lung Cancer
10:20 AM
Break and Exhibits
11:20 AM
Update on Cellular Therapy in Lymphoma
11:40 AM
Sarcoma
12:00 PM
Multiple Myeloma
12:20 PM
Panel Discussion and Q&A - Hematological Malignancies
12:35 AM
Lifestyle Tips and Strategies
1:40 PM
Housekeeping and Survey
1:45 PM
Molecular Tumor Board Panel
2:25 AM
Survivorship and Sexual Health
2:45 AM
West Cancer Center - The Unicorn of Cancer Centers
3:05 PM
Networking Reception
4:05 PM
Adjourn
Adgenda Subject To Change. All times are CST.
-
Determine best application of new targeted therapies in patients with early stage and metastatic disease
Discuss the advances in systemic therapy likely to change current practices for treatment of breast cancer
Know how to utilize genomic tools for systemic therapy decision making and prediction of treatment response.
Be familiar with germ-line genetic testing options for hereditary breast cancer, including advantages and disadvantages of extended panel testing
Evaluate local therapy options for operable breast cancer depending on stage, and the use of neoadjuvant therapy
Identify evidence-based recommendations for decreasing symptoms and improving quantity and/or quality of life in survivors
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of TBD ANCC contact hours.Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of TBD AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of TBD knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program